Prevalência da retinopatia diabética em pacientes com diabetes mellitus tipo 2 na população de Vespasiano
Nenhuma Miniatura disponível
Arquivos
Data
2022-11-18
Tipo de documento
Monografia
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Ciências da Saúde
Modalidade de acesso
Acesso aberto
Editora
Autores
AZEVEDO, Ingridy Maria Diniz Melo
ALVES, Ana Carolina Dalsecco
MATTOS, Manuela Pitella de
PELÚCIO, Ana Laura Pimenta
SOUSA, Laura Bragança Rabelo de
Orientador
DAMÁSIO, Mariana Amaranto de Souza
Coorientador
LEITE, Marina Costa
Resumo
O Diabetes Mellitus tipo 2 (DM2) é uma patologia caracterizada por hiperglicemia, devido a perda progressiva de secreção de insulina pelas células beta pancreáticas. Essa doença está associada a complicações macrovasculares e microvasculares, dentre elas a retinopatia diabética (RD). A RD, frequentemente, está presente na população de idade ativa e é a principal causa de cegueira evitável nos países desenvolvidos. A doença possui início insidioso e alta taxa de progressão sendo relacionada, principalmente, à duração do diabetes e nível de controle glicêmico. Faz-se necessário programas públicos de prevenção, diagnóstico e tratamento precoce que visam a melhora do prognóstico da RD, bem como a redução do risco de dano visual irreversível. Desse modo, no presente estudo foram analisados dados extraídos de prontuários referentes aos pacientes previamente diagnosticados com DM2, que participaram do mutirão de retinopatia diabética ocorrido em 02/07/2022, residentes de Vespasiano, Minas Gerais, que realizam tratamento nas unidades básicas de saúde ou com médicos endocrinologistas do município. Tais dados coletados tem como objetivo primário avaliar a prevalência da retinopatia diabética nessa população.
Type 2 Diabetes Mellitus (DM2) is a pathology characterized by hyperglycemia, due to progressive loss of insulin secretion by pancreatic beta cells. This disease is associated with macrovascular and microvascular complications, among them the diabetic retinopathy (DR). DR is often present in the working-age population and is the leading cause of avoidable blindness in developed countries. The disease has an insidious onset and a high progression rate, being mainly related to the duration of diabetes and the level of glycemic control. Public programs of prevention, diagnosis, and early treatment are needed to improve the prognosis of DR, as well as to reduce the risk of irreversible visual damage. Thus, the present study analyzed data extracted from medical records of patients previously diagnosed with DM 2, who participated in the community effort for diabetic retinopathy that took place on July 2, 2022, residents of Vespasiano, Minas Gerais, who are being treated at basic health units or by endocrinologists in the city. The primary objective of the data collected was to assess the prevalence of diabetic retinopathy in this population.
Type 2 Diabetes Mellitus (DM2) is a pathology characterized by hyperglycemia, due to progressive loss of insulin secretion by pancreatic beta cells. This disease is associated with macrovascular and microvascular complications, among them the diabetic retinopathy (DR). DR is often present in the working-age population and is the leading cause of avoidable blindness in developed countries. The disease has an insidious onset and a high progression rate, being mainly related to the duration of diabetes and the level of glycemic control. Public programs of prevention, diagnosis, and early treatment are needed to improve the prognosis of DR, as well as to reduce the risk of irreversible visual damage. Thus, the present study analyzed data extracted from medical records of patients previously diagnosed with DM 2, who participated in the community effort for diabetic retinopathy that took place on July 2, 2022, residents of Vespasiano, Minas Gerais, who are being treated at basic health units or by endocrinologists in the city. The primary objective of the data collected was to assess the prevalence of diabetic retinopathy in this population.
Palavras-chave
retinopatia diabética, diabetes tipo 2, hiperglicemia, controle glicêmico